首页|真武汤联合沙库巴曲缬沙坦治疗心力衰竭的效果观察

真武汤联合沙库巴曲缬沙坦治疗心力衰竭的效果观察

扫码查看
目的:探究真武汤联合沙库巴曲缬沙坦治疗心力衰竭的效果.方法:选择 2022 年 1 月—2024 年 1 月在滕州市中医医院治疗的心力衰竭患者 86 例,应用随机数字表法将其分为对照组(予以沙库巴曲缬沙坦)及观察组(沙库巴曲缬沙坦联合真武汤),各 43 例.对比两组中医症候积分、心功能、炎症指标、N末端脑钠肽前体(NT-proBNP)、氧化应激、总有效率.结果:治疗前,两组中医症候积分(胸闷、心悸、气短、神疲乏力、面肢浮肿、面色晦暗)、左心室收缩末期内径(LVESD)、左心室舒张末期内径(LVEDD)、左室射血分数(LVEF)、C反应蛋白(CRP)、白细胞介素-6(IL-6)、肿瘤坏死因子-α(TNF-α)、同型半胱氨酸(Hcy)、丙二醛(MDA)、超氧化物歧化酶(SOD)、NT-proBNP比较,差异均无统计学意义(P>0.05);治疗后,两组胸闷、心悸、气短、面肢浮肿、神疲乏力、面色晦暗评分和LVESD、LVEDD、CRP、IL-6、TNF-α、Hcy、MDA、NT-proBNP均降低,观察组均低于对照组,LVEF、SOD均升高,观察组均高于对照组,差异均有统计学意义(P<0.05).观察组治疗总有效率高于对照组,差异有统计学意义(P<0.05).结论:心力衰竭患者接受真武汤联合沙库巴曲缬沙坦治疗可降低NT-proBNP,改善心功能,抑制炎症反应,减轻氧化应激,疗效显著.
Observation on Effect of Zhenwu Decoction Combined with Sacubitril Valsartan in the Treatment of Heart Failure
Objective:To explore the effect of Zhenwu Decoction combined with Sacubitril Valsartan in the treatment of heart failure.Method:A total of 86 patients with heart failure treated in Tengzhou Traditional Chinese Medical Hospital from January 2022 to January 2024 were selected and divided into control group(given Sacubitril Valsartan)and observation group(given Sacubitril Valsartan combined with Zhenwu Decoction)by random number table method,with 43 cases in each group.TCM symptoms scores,heart function,inflammatory indexes,N-terminal pro-brain natriuretic peptide(NT-proBNP),oxidative stress and total effective rate were compared between the two groups.Result:Before treatment,there were no significant differences in TCM symptoms scores(chest distress,palpitation,shortness of breath,spiritlessness and fatigue,facial and lower limbs edema,dim complexion),left ventricular end-systolic diameter(LVESD),left ventricular end-diastolic diameter(LVEDD),left ventricular ejection fraction(LVEF),C reactive protein(CRP),interleukin-6(IL-6),tumor necrosis factor-α(TNF-α),homocysteine(Hcy),malondialdehyde(MDA),superoxide dismutase(SOD)and NT-proBNP between two groups(P>0.05).After treatment,the chest distress,palpitation,shortness of breath,spiritlessness and fatigue,facial and lower limbs edema,dim complexion scores and LVESD,LVEDD,CRP,IL-6,TNF-α,Hcy,MDA and NT-proBNP were all decreased in both groups,those in the observation group were lower than those in the control group,and the LVEF and SOD were all increased in both groups,those in the observation group were higher than those in the control group,the differences were statistically significant(P<0.05).The total effective rate of the observation group was higher than that of the control group,the difference was statistically significant(P<0.05).Conclusion:Zhenwu Decoction combined with Sacubitril Valsartan in patients with heart failure can reduce NT-proBNP,improve cardiac function,inhibit inflammatory response and alleviate oxidative stress,with significant curative effect.

Zhenwu DecoctionSacubitril ValsartanHeart failureHeart functionOxidative stress

宋现丽、韩金国、张明建

展开 >

滕州市中医医院心血管科 山东 滕州 277599

滕州市中医医院手足外科 山东 滕州 277599

真武汤 沙库巴曲缬沙坦 心力衰竭 心功能 氧化应激

2024

中国医学创新
中国保健协会

中国医学创新

影响因子:1.706
ISSN:1674-4985
年,卷(期):2024.21(15)
  • 17